Clinical Trial Update: Pharmacokinetic Study of Carboplatin in Pediatric Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 pharmacokinetic study of carboplatin in pediatric patients undergoing hematopoietic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: The Korean Society of Pediatric Hematology Oncology | Conditions: Pediatric Solid Tumor | Phase 2 | Status: UNKNOWN